Trial Profile
Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Hypogonadism; Obesity
- Focus Therapeutic Use
- 28 Jan 2020 Status changed from recruiting to completed.
- 11 Nov 2016 New trial record